Do Kawasaki disease patients without coronary artery abnormalities need a long-term follow-up? A myocardial single-photon emission computed tomography pilot study

Journal of Paediatrics and Child Health

Volumn 45, Issue 7-8, 2009, Pages 419-424

  Zanon, Giulia ^a   Zucchetta, Pietro ^a   Varnier, Maurizio ^a   Vittadello, Fabio ^a   Milanesi, Ornella ^a   Zulian, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Coronary aneurysms; Kawasaki disease; Outcome; Scintigraphy; SPECT

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DEMOGRAPHY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; LONG TERM CARE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PILOT STUDY; PREDICTIVE VALIDITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; CORONARY ANEURYSM; CORONARY VESSEL ANOMALIES; FEMALE; HUMANS; ITALY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PILOT PROJECTS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 68749122234     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2009.01531.x     Document Type: Article

References (23)

1. Taubert K, Rowley A, Shulman S. A nationwide survey of Kawasaki disease and acute rheumatic fever. J. Pediatr. 1991 119 : 279 82.
2. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment and long-term management of Kawasaki disease. Circulation 2004 110 : 2747 71.
3. Kato H, Sugimura T, Akagi T et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996 94 : 1379 85.
4. Dhillon R, Clarckson P, Donald AE et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996 94 : 2103 6.
5. Furuyama H, Odagawa Y, Katoh C et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J. Pediatr. 2003 142 : 149 54.
6. Japan MCLS Research Committee. Kawasaki disease: diagnosis, pathology, treatment and epidemiology. Department of Epidemiology, Institute of Public Health 4/6/1 Shirokanedai Minato-ku, Tokyo 108, Japan May 1980.
7. De Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J. Pediatr. 1998 133 : 254 8.
8. Schaller JC, Wedgewood RJ. Vasculitis Syndromes. In Behrman RE, Kliegman R, Jenson HB (eds). Nelson textbook of paediatrics XVIIth edition. W.B. Saunders Co., Philadelphia, 2004 2398 9.
9. Fukuda T, Ishibashi M, Shinohara T, Miyake T, Kudoh T, Saga T. Follow-up assessment of the collateral circulation in patients with Kawasaki disease who underwent dipyridamole stress technetium-99m tetrofosmin scintigraphy. Pediatr. Cardiol. 2005 26 : 558 64.
10. Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics 1999 104 : e57.
11. Suzuki A, Kamiya T, Kuwahara N et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr. Cardiol. 1986 7 : 3 9.
12. Dajani AS, Taubert KA, Takahashi M et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994 89 : 916 22.
13. Fukazawa M, Fukushige, Takauchi T, Fukushige J. Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram. Pediatr. Cardiol. 1993 14 : 67 74.
14. Paridon SM, Galioto FK, Vincent JA, Tomassoni TL, Sullivan NM, Bricker JT. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J. Am. Coll. Cardiol. 1995 25 : 1420 4.
15. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr. Jpn. 1991 33 : 805 10.
16. Beiser AS, Takahasha M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. Am. J. Cardiol. 1998 81 : 1116 20.
17. Muta H, Ishii M, Sakaue T et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Paediatrics 2004 114 : 751 4.
18. Fukuda T, Ishibashi M, Yokoyama T et al. Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy. J. Nucl. Cardiol. 2002 6 : 632 7.
19. Travin MI, Katz MS, Moulton AW, Miele NJ, Sharaf BL, Johnson LL. Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenosis and multivessel disease in women versus men. J. Nucl. Cardiol. 2000 7 : 213 20.
20. Muzik O, Paridon SM, Singh TP, Morrow WR, Dayanikli F, Di Carli MF. Quantification of myocardial blood reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J. Am. Coll. Cardiol. 1996 28 : 757 62.
21. Yutani C, Go S, Kamiya T et al. Cardiac biopsy of Kawasaki disease. Arch. Pathol. Lab. Med. 1981 105 : 470 3.
22. Fu YC, Kao CH, Hwang B, Jan SL, Chi CS. Discordance between dypiridamole stress Tc-sestamibi SPECT and coronary angiography in patients with Kawasaki disease. J. Nucl. Cardiol. 2002 9 : 41 6.
23. Kimball TR, Witt SA, Daniels SR. Dobutamine stress echocardiography in the assessment of suspected myocardial ischemia in children and young adults. Am. J. Cardiol. 1997 79 : 380 4.